Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial
根据SGLT2i的使用情况，口服索马鲁肽对2型糖尿病患者心血管结局的影响：SOUL随机试验的预设分析
期刊:Circulation
影响因子:38.6
doi:10.1161/CIRCULATIONAHA.125.074545
Marx, Nikolaus; Deanfield, John E; Mann, Johannes F E; Arechavaleta, Rosario; Bain, Stephen C; Bajaj, Harpreet S; Bayer Tanggaard, Katrine; Birkenfeld, Andreas L; Buse, John B; Davicevic-Elez, Zaklina; Desouza, Cyrus; Emerson, Scott S; Engelmann, Mads D M; Hovingh, G Kees; Inzucchi, Silvio E; Jhund, Pardeep S; Mulvagh, Sharon L; Pop-Busui, Rodica; Poulter, Neil R; Rasmussen, Søren; Tu, Shih-Te; McGuire, Darren K
